Table 4. Multivariate Cox regression analysis for vitamin D and other selected possible predictors of mortality in patients with AKI.
25(OH)Dnmol/L | 1, 25(OH)2Dpmol/L | BsmI | FokI | Age | Gender | SOFA score | ||||||||
HR | p | HR | p | HR | p | HR | p | HR | p | HR | p | HR | p | |
Model 1 | 1.007 | 0.522 | 1.003 | 0.326 | / | / | / | / | / | / | / | / | / | / |
Model 2 | 1.006 | 0.571 | 1.003 | 0.404 | 0.409 | 0.224 | 1.172 | 0.739 | / | / | / | / | / | / |
Model 3 | 1.013 | 0.799 | 1.002 | 0.514 | 0.360 | 0.168 | 1.131 | 0.799 | 0.987 | 0.172 | 1.148 | 0.737 | / | / |
Model 4 | 1.007 | 0.593 | 1.004 | 0.136 | 0.759 | 0.721 | 0.639 | 0.360 | 0.998 | 0.843 | 0.571 | 0.220 | 1.314 | <0.001 |
Note: The multivariate analysis sequentially adjusted the models for covariates as follows: Model 1, unadjusted; Model 2, adjusted for VDR polymorphisms; Model 3, adjusted for age, gender, and VDR polymorphisms; Model 4, adjusted for age, gender, SOFA score, and VDR polymorphisms.
Abbreviations: 25(OH)D, 25-hydroxyvitamin D; 1,25(OH)2D, 1,25-dihydroxyvitamin D; SOFA, Sequential Organ Failure Assessment.